| William Sandborn, MD Dr. William Sandborn completed medical school and an internal medicine residency at Loma Linda University in Loma Linda California. He completed a gastroenterology fellowship at the Mayo Clinic in Rochester Minnesota in 1993. From 1993-2010, he was on the faculty of the Mayo Clinic, rising to Professor of Medicine, Vice Chairman of the Division of Gastroenterology and Hepatology, and Associate Dean of Research for Intellectual Property and Industry Relations. In 2011 he became Professor of Clinical Medicine and Chief of the Division of Gastroenterology at the University of California San Diego. Dr. Sandborn has published over 368 peer reviewed articles including articles in the New England Journal of Medicine, the Lancet, JAMA, the Annals of Internal Medicine, and Gastroenterology. His research interests are clinical trials and clinical pharmacology related to inflammatory bowel disease. |
Dr. Stephen Hanauer is a world leader in the treatment of inflammatory bowel diseases (IBD). He qualified MD with Honors in 1977 at the University of Illinois. He completed his internship, residency and fellowship at the University of Chicago, and has remained there ever since. He is the Director of the Logan Center for GI research and, in 1999, he was made the Gastrointestinal Research Foundation Professor of Medicine, in honor of Dr. Joseph B. Kirsner and has been Chief of the Section of Gastroenterology, Hepatology and Nutrition since 2000 at the University of Chicago. Dr. Hanauer's interests primarily pertain to the treatment of inflammatory bowel disease. He has maintained one of the world's largest databases of patients with these disorders and has worked with both the FDA and industry to develop new therapeutic approaches to these chronic, medically incurable disorders. In addition to being the lead investigator of a large number of multicenter trials, he has been active in the development of new means of patient categorization related to prognosis and severity of disease, developed guidelines for the American College of Gastroenterology to treat Crohn's disease and has led the group that identified the first gene associated with IBD. Dr. Hanauer is also the author of numerous articles, editorials, chapters, books, abstracts and monographs on IBD, its causes and its treatment. He is the past chair of the Immunology, Microbiology and Inflammatory Bowel Disease Section of the American Gastroenterological Association (AGA). Dr. Hanauer is also a recipient of the AGA's Fiterman Award for Clinical Research and the AGA's Janssen Award for Clinical Excellence. Additionally, he has been named one of America's Top Doctors by Castle Connolly Medical Ltd. Dr. Hanauer previously served as a member and chair of the Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee, and as chair of the International Organization for Inflammatory Bowel Disease. He is currently secretary of the American College of Gastroenterology, and a member of the GI Specialty Board of Internal Medicine. |
| David T. Rubin, MD David T. Rubin, MD, is Associate Professor of Medicine, Department of Medicine, Co-Director, Inflammatory Bowel Disease Center, and Program Director, Fellowship in Gastroenterology, Hepatology, and Nutrition at the University of Chicago (UC). He also is an associate faculty member at the MacLean Center for Clinical Medical Ethics and an associate investigator at the UC Comprehensive Cancer Center. After graduating with honors from the UC Pritzker School of Medicine, Dr. Rubin started his career in medicine and is board certified in Gastroenterology. A member of many professional organizations, including the American College of Gastroenterology, the American Gastroenterological Association, the Crohn's and Colitis Foundation of America, the American Society for Gastrointestinal Endoscopy, and the Gastroenterology Research Group, Dr. Rubin also is a Fellow of AGA and a Fellow of the ACG. Chosen by his peers as a member of Best Doctors (recognized for superior clinical ability) and America's Top Physicians (Gastroenterology), he received the American College of Gastroenterology Governor's Award of Excellence in Clinical Research (2003), the Cancer Research Foundation Young Investigator's Award (2004), and the UC Postgraduate Teaching Award in recognition of significant contributions for fellowship education (2006). Dr. Rubin is an author or coauthor of dozens of peer-reviewed articles on topics such as Inflammatory Bowel Disease (IBD), virtual colonoscopy, genetic testing in IBD, cancer in IBD, as well as many book chapters, abstracts, and presentations. From 1991 through the present, he has been the recipient of numerous grants and awards, and has been awarded a patent in a method of computer-aided detection of three-dimensional lesions. His principle research interests include colon cancer screening, prevention, and genetics; virtual colonoscopy; IBD therapies and genetics; teaching medicine; humanism in medicine and medical education; and clinical medical ethics. |
